Table
2: The effect of pequi
oil compared to placebo in patients with SLE in several variables.
|
Variables |
Δ (initial - final) |
Difference between groups |
|
P-values |
|
Placebo Group |
Pequi oil |
Placebo - Pequi oil |
||
|
DNA damage index |
0.54 ± 1.45 |
1.68 ± 1.45 |
-1.42 ± 1.74 |
0.5818 |
|
SLEDAI |
0.12 ± 0.81 |
-1.01 ± 0.88 |
1.12 ± 1.14 |
0.3598 |
|
BMI |
0.13 ± 0.11 |
0.15 ± 0.11 |
-0.02 ± 0.14 |
0.8884 |
|
WC |
0.47 ± 0.64 |
-0.01 ± 0.64 |
0.48 ± 0.73 |
0.5994 |
|
HC |
0.28 ± 0.42 |
0.73 ± 0.44 |
-0.45 ± 0.60 |
0.4632 |
|
W/H |
0.00 ± 0.01 |
-0.00 ± 0.01 |
0.01 ± 0.01 |
0.4626 |
|
AC adequacy |
-0.01 ± 0.54 |
0.46 ± 0.54 |
-0.47 ± 0.74 |
0.5460 |
|
TS adequacy |
1.24 ± 1.87 |
3.43 ± 1.87 |
-2.18 ± 2.65 |
0.4164 |
|
AMC adequacy |
-0.24 ± 0.70 |
-0.47 ± 0.70 |
0.23 ± 1.00 |
0.8172 |
|
Glucose |
-0.59 ± 3.21 |
1.03 ± 2.01 |
-1.62 ± 3.23 |
0.6805 |
|
AST |
-0.14 ± 1.33 |
-0.81 ± 1.27 |
0.67 ± 1.79 |
0.7192 |
|
ALT |
0.48 ± 1.47 |
-0.85 ± 1.40 |
1.33 ± 1.99 |
0.5180 |
|
GGT |
-6.07 ± 2.00 |
-3.98 ± 1.28 |
-2.08 ± 2.38 |
0.4092 |
|
hs-CRP |
-0.07 ± 0.06 |
0.15 ± 0.06 |
-0.22 ± 0.08 |
0.0161* |
|
Uric acid |
0.41 ± 0.25 |
0.06 ± 0.19 |
0.34 ± 0.26 |
0.2963 |
|
Total cholesterol |
2.74 ± 3.50 |
-3.26 ± 3.42 |
5.70 ± 4.76 |
0.2339 |
|
Triglycerides |
12.71 ± 5.84 |
-0.03 ± 5.71 |
12.75 ± 7.88 |
0.1327 |
|
HDL |
0.13 ± 1.36 |
-2.25 ± 1.32 |
2.38 ± 1.84 |
0.2218 |
|
LDL |
0.15 ± 3.23 |
-0.90 ± 3.15 |
1.05 ± 4.37 |
0.8190 |
|
VLDL |
2.44 ± 1.49 |
0.01 ± 1.22 |
2.43 ± 1.56 |
0.1440 |
|
Globulin |
-0.02 ± 0.08 |
-0.01 ± 0.07 |
-0.01 ± 0.10 |
0.9280 |
SLEDAI:
Systemic Lupus Erythematosus Disease Activity Index;
BMI: Body Mass Index; WC: Waist Circumference; HC: Hip Circumference; W/H:
Waist/hip ratio; AC: Arm Circumference; TS: Triceps Skinfold thickness; AMC:
Arm Muscle Circumference; AST: Aspartate Transaminase; ALT: Alanine
aminotransferase; GGT: Gamma-Glutamyl Transferase; hs-CRP:
High-Sensitivity C-reactive protein (hs-CRP); HDL:
High-Density Lipoprotein; LDL: Low Density Lipoprotein; VLDL: Very Low Density
Lipoprotein; *p-value with statistical significance. Values
expressed as mean ± standard least squares error.